Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study

Journal of Clinical Oncology

Volumn 16, Issue 7, 1998, Pages 2459-2465

  Wozniak, Antoinette J ^a   Crowley, John J ^a   Balcerzak, Stanley P ^a   Weiss, Geoffrey R ^a   Spiridonidis, C Harris ^a   Baker, Laurence H ^a   Albain, Kathy S ^a   Kelly, Karen ^a   Taylor, Sar A ^a   Gandara, David R ^a   Livingston, Robert B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; LORAZEPAM; NAVELBINE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE CALCULATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031861215     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.7.2459     Document Type: Article

References (24)

1. Ginsberg RJ, Kris MG, Armstrong JG: Cancer of the lung, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincot, 1993, pp 673-758
2. Bunn PA Jr: The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol 16:10-21, 1989 (suppl 6)
3. Schabel FM, Trader MW, Laster WR, et al: Cis-dichlorodiammine-platinum (II): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63:1459-1473, 1979
4. Klastersky J: VP-16 and cisplatin in the treatment of non-small cell lung cancer. Semin Oncol 12:17-20, 1985 (suppl 2)
5. Gralla RJ, Kris MG: Chemotherapy in non-small cell lung cancer: Results of recent trials. Semin Oncoi 15:2-5, 1988 (suppl 4)
6. Gralla RJ, Caspar ES, Elsen DP, et al: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med 95:414-420, 1981
7. Woodcock TM, Blumenreich MS, Richman SP, et al: Combination chemotherapy with cis-diammine-dichloroplatinum and vinblastine in advanced non-small cell lung cancer. J Clin Oncol 1:247-250, 1983
8. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al: Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 7:1602-1613, 1989
9. Cross S, Wright M, Morimoto M, et al: Experimental activity of Navelbine. Semin Oncol 16:15-20, 1989 (suppl 4)
10. Depierre A, Lemarie E, Dabouis G, et al: A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer. Am J Clin Oncol 14:115-119, 1991
11. Crawford J, O'Rourke M, Schiller JH, et al: Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol 14:2774-2784, 1996
12. Le Chevalier T, Brisgand D, Douillard J-Y, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Mantel N: Evaluation of survival data and two new rank order statistics arising in the consideration. Cancer Chemother Rep 50:163-170, 1966
15. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
16. Rapp EA, Pater JL, William A, et al: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer - Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988
17. Panettiere FJ, Vance RB, Stuckey WJ: Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: A Southwest Oncology Group study. Cancer Treat Rep 67:399-400, 1983
18. Klastersky J, Sculier JP, Ravez P, et al: A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. J Clin Oncol 4:1780-1786, 1986
19. Gandara DR, Crowley J, Livingston RB, et al: Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group. J Clin Oncol 11:873-878, 1993
20. Klastersky JP, Schulier G, Bureau P, et al: Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer. J Clin Oncol 7:1087-1092, 1989
21. Kawahara M, Furuse K, Kodama N, et al: A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma. Cancer 68:714-719, 1991
22. Weick JK, Crowley J, Natale RB, et al: A randomized trial of five cisplatin - containing treatments in patients with metastatic non-small-cell lung cancer: A Southwest Oncology Group study. J Clin Oncol 9:1157-1162, 1991
23. Livingston RB: Treatment of advanced non-small cell lung cancer: The Southwest Oncology Group experience. Semin Oncol 15:37-41, 1988 (suppl 7)
24. Bunn PA Jr: The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Semin Oncol 23:18-25, 1996 (suppl 16)